Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Healthcor Management Reduces Position in Allscripts Healthcare Solutions Inc (MDRX)

Arthur Cohen and Joseph Healey‘s Healthcor Management, revealed, in a newly amended filing with the SEC, decreasing its holding in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), currently owning 10.0 million shares of the company, from 11.0 million held at the end of September, as revealed in the fund’s latest 13F. Currently Healthcor’s activist stake, amasses 5.6% of the company’s common stock, and at the current value of Allscripts Healthcare Solutions shares, it is worth $150.2 million.

Arthur B Cohen and Joseph Healey

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) makes it easy for healthcare experts to generate world-class outcomes through its insightful connectivity and information solutions. The company has recently announced the expansion of its operations in India, one of its key emerging markets, through opening a new product development center in Baroda. The facility is expected to help the company to consolidate its product development team, the company said in a statement. In this way, Allscripts’ center in Baroda will have a team consisting of around 400 employees, up from the current 275.

Several hedge funds have been bullish on Allscripts so far. Despite trimming the holding, Healthcor Management is still one of the most significant stockholders of the company. Eminence Capital, managed by Ricky Sandler, is another holder of a large position, revealing ownership of almost 7.8 million shares, worth $115.8 million in its latest 13F. It is followed by Clifton S. Robbins‘ Blue Harbour Group, which disclosed a $108 million stake, which amasses 7.3 million shares.

According to another recent filing of Healthcor Management, the fund has initiated a passive stake in Five Prime Therapeutics Inc (NASDAQ:FPRX), owning currently 965,000 shares, equal to 5.73% of the outstanding common stock.

Disclosure: none

Recommended Reading:

Jeff Smith, Starboard Value Add to Position in Office Depot Inc (ODP)

Zac Hirzel Gets Appointed to the Board of Hawaiian Holdings, Inc. (HA)

Bill Gates’ Cascade Investment Acquires a Resort from Strategic Hotels and Resorts Inc (BEE)

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.